Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Paulina E. Stürzebecher"'
Autor:
Paulina E. Stürzebecher, Ioanna Gouni-Berthold, Christina Mateev, Ole Frenzel, Stephan Erbe, Jes-Niels Boeckel, Markus Scholz, Ulrike Schatz, Oliver Weingärtner, Ursula Kassner, Ulrich Laufs, A. Baessler, K. Borucki, G. Heine, G. Hoh, R. Klingenberg, W. Koenig, K. Parhofer, V. Rettig-Ewen, V. Schettler, S. Schirmer, S. Seiler-Mußler, K. Stach-Jablonski, J. Taggeselle, A. Tamm, A. Vogt
Publikováno v:
The Lancet Regional Health. Europe, Vol 43, Iss , Pp 100981- (2024)
Summary: Background: Statin intolerance is associated with increased cardiovascular risk. Symptoms and patients’ characteristics are incompletely known. We aimed to analyse the health-related quality of life (QOL) associated with statin intolerance
Externí odkaz:
https://doaj.org/article/f84e48da1e8641579edef1b63730eeb2
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract The inability to tolerate sufficient doses of statins, statin intolerance (SI), contributes to the non-achievement of guideline-recommended low-density lipoprotein cholesterol (LDL-C) treatment targets. Patients with SI require alternative l
Externí odkaz:
https://doaj.org/article/0bd1c7aae4eb481a8067998efd7df1ea
Publikováno v:
Atherosclerosis. 367:24-33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9605ccd8efdfbed4cb99be5598cf4ca7
https://doi.org/10.1016/j.atherosclerosis.2023.01.014
https://doi.org/10.1016/j.atherosclerosis.2023.01.014
Publikováno v:
European Heart Journal. 44:1446-1448
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f55e6eb8bce752c226ab3543d5730fc
https://doi.org/10.1093/eurheartj/ehac783
https://doi.org/10.1093/eurheartj/ehac783
Autor:
PAULINA E. STÜRZEBECHER, SUSAN KRALISCH, MARIE R. SCHUBERT, VANINA FILIPOVA, ANNETT HOFFMANN, MATTHIAS BLÜHER, KONSTANZE MIEHLE, THOMAS EBERT, ULRICH LAUFS, ANKE TÖNJES, JES-NIELS BOECKEL
Publikováno v:
Diabetes. 71
Introduction: Adipose tissue (AT) is involved in interorgan crosstalk by releasing adipokines such as leptin. Loss of AT, as seen in the human disease of lipodystrophy syndromes (LD) , results in low leptin levels, severe metabolic pathologies and in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6359b51c35fe90ac08ff74f09c9e6feb
https://doi.org/10.2337/db22-415-p
https://doi.org/10.2337/db22-415-p